Ligufalimab, CAS 2428381-55-7

Product Description: Ligufalimab (AK 117) is a humanized IgG4 anti-CD47 monoclonal antibody. Ligufalimab does not induce RBC hemagglutination, and induces phagocytosis. Ligufalimab shows anti-tumor activity[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Qu T, et al. Ligufalimab, a novel anti-CD47 antibody with no hemagglutination demonstrates both monotherapy and combo antitumor activity. J Immunother Cancer. 2022 Nov;10(11):e005517.

CAS Number: 2428381-55-7

Molecular Weight: N/A

Compound Purity: 98.81

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: CD47;Interleukin Related

• SKU: MEXHY-P99706-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99706-5
• Package Unit: 5 mg
• Quantity Unit: STK
• Conjugate: Unconjugated